Other researchers found that a combined signature of high LAMA3, LAMB3, and LAMC2 expression was a stronger predictor of poor prognosis in pancreatic adenocarcinoma than individual genes [26]. This evidence concerns the gene LAMB3 and pancreatic adenocarcinoma.